Facebook
X
LinkedIn
Forward| Title | Credit | Series date |
Member price |
Non-member price |
|---|---|---|---|---|
|
Medically Complex Youth in Foster Care 1.0 NAPNAP Contact Hour. This continuing education activity is offered for free to NAPNAP Members until 1/31/2026. For non-members, this continuing education activity rate is $20. |
|
01/22/2025 to 01/31/2027 | $0.00 | $20.00 |
|
Recognition and Stabilization of Infants with Ductal Dependent Cardiac Lesions Free March PedsCE Course - Exclusive benefit for NAPNAP members! 0.75 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $7.5 for NAPNAP Members. For non-members, this continuing education activity rate is $15. This course is an archived session from NAPNAP's Pediatric Virtual Symposium: 2024 Targeted Topics. Infants born with congenital heart disease may be dependent on a patent ductus arteriosus to maintain blood flow to either the lungs or body. Some infants may not be recognized to have ductal dependent cardiac disease until the ductus arteriosus is closing and the patient is showing signs of poor perfusion or hypoxia. Detection and management of ductal dependence is critical to stabilize these patients until corrective procedures or surgeries can be offered. |
|
11/15/2024 to 11/30/2026 | $0.00 | $15.00 |
|
Guidance for Implementing the AAP's 2023 Clinical Practice Guideline for the Evaluation and Treatment of Pediatric Obesity in Primary Care 1.00 NAPNAP Contact Hour. This course is an archived session from NAPNAP's Pediatric Virtual Symposium: 2024 Targeted Topics. The 2023 American Academy of Pediatrics (AAP) CPG for the Evaluation and Treatment of Obesity in Children and Adolescents recommends that children 2-18 years with overweight/obesity be comprehensively evaluated for comorbidities and offered multicomponent, family-based, Intensive Health Behavior and Lifestyle Treatment (IHBLT). This session will focus on the core components of IHBLT and the associated health outcomes. Additionally, participants will learn how to locate recognized Family Healthy Weight Programs and steps to take if there are no local programs. Led by a member of the AAP clinical practice guideline writing team and a member of the NAPNAP Childhood Obesity SIG, this session will help primary care providers assess and build their capacity around IHBLT. |
|
11/15/2024 to 11/30/2026 | $0.00 | $0.00 |
|
RSV 2024-2025 – Is Your Pediatric Practice Ready? 1.0 NAPNAP Contact Hour of which 0.75 contain pharmacology content. This continuing education activity is free to National Association of Pediatric Nurse Practitioners (NAPNAP) members and non-members. This course will provide the necessary education enabling pediatric practice providers and staff to successfully prevent RSV in the most vulnerable pediatric populations using the recommendations to administer the appropriate RSV prevention to infants based on weight, age, pre-term birth history, presence of chronic conditions and race. |
|
10/10/2024 to 10/31/2026 | $0.00 | $0.00 |
|
Increasing Access to Mental Health Care in Massachusetts 0.5 NAPNAP Contact Hour. This continuing education activity is free for NAPNAP Members and non-members. This project is supported by the Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) and is specific for those interested in increasing access to mental health care in Massachusetts. |
|
07/19/2024 to 12/31/2026 | $0.00 | $0.00 |
|
Navigating Pediatric Obesity Treatment: Exploring the Latest AAP Guidelines and Strategies 1.0 NAPNAP contact hour of which 0.25 contain pharmacology content. This continuing education activity is offered FREE to Members and Nonmembers. The purpose of this program is to inform primary care pediatric health care providers about the management of children and adolescents with obesity guided by the American Academy of Pediatrics (AAP) Clinical Practice Guidelines published in 2023. The presentation content focuses on how to implement best practices for the management of children and adolescents with obesity including pharmacotherapy. Additionally, guidance on the AAP resources and how to access and utilize these tools will be discussed. |
|
05/17/2024 to 05/31/2026 | $0.00 | $0.00 |
|
Tick Talk: Digging Deeper into Lyme Disease 2024 1.0 NAPNAP Contact Hour. This continuing education activity is free to National Association of Pediatric Nurse Practitioners (NAPNAP) members and non-members. This course is a recorded presentation for NAPNAP's 2024 National Conference. Lyme disease is the most common vector-borne disease in the U.S., with a childhood peak at five to nine years of age. Pediatric-focused APRNs in both high and low incidence areas may encounter patients in whom Lyme disease is a concern. This presentation will provide an in-depth review of Lyme disease testing and interpretation, discuss when (and when not) to treat and examine the current knowledge regarding prolonged symptoms. |
|
06/27/2024 to 06/30/2026 | $0.00 | $0.00 |
|
2025 Pediatric Pharmacology Update 1.00 NAPNAP Contact Hour of which 1.00 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. A fast-paced update on pediatric prescribing including newly approved or relabeled pediatric medications, and pediatric pharmacology studies in process. Issues that affect pediatric practice including drug shortages, emerging poisoning hazards, and new guidelines will be discussed. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
Pharmacologic Management of Cardiac Dysrhythmias 1.25 NAPNAP Contact Hour of which 1.25 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. This presentation will focus on the treatment of common dysrhythmias seen in children, specifically pharmacologic options. We will review both inpatient and outpatient management of various dysrhythmias. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
Human Trafficking: Raising Awareness to Identify Victims in the Clinical Setting Providers must register for a free PedsCE account, and be logged in to watch the webinar and receive the certificate. This course was created in collaboration with NAPNAP Partners for Vulnerable Youth. This continuing education activity is offered free for NAPNAP members and nonmembers. |
|
10/06/2020 to 08/29/2027 | $0.00 | $0.00 |
|
Keeping Current in Atopic Diseases 1.25 NAPNAP Contact Hour of which 1.25 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. The field of Allergy & Immunology continues to expand and incorporate new therapeutics to manage difficult diseases. In 2024, new drugs have been approved that can revolutionize treatment for disease management. Patients will look to their primary care clinicians to be knowledgeable and a resource for these therapeutics. This panel will include three NP experts from food allergy centers at the Children’s Hospital of Philadelphia and University of Texas Southwestern and will discuss biologics, immunotherapy options and non-IgE mediated disease updates for food allergy. NAPNAP’s Asthma and Allergy SIG is pleased to support this session. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
Leucovorin in Autism: An Evidence-Based and Clinically Informed Approach 1.25 NAPNAP Contact Hours of which 1.25 contains pharmacology content. This continuing education activity is offered free for NAPNAP Members and non-members. This presentation synthesizes the evidence on folinic acid in autism, with an emphasis on advances since 2018 within the context of foundational work. We will examine the pathophysiology of cerebral folate deficiency (CFD), clarify genetic contributors (e.g., FOLR1 and folate-pathway variants), and review clinical testing with folate receptor-α autoantibodies and related labs. Practical treatment guidance will cover formulation selection, dosing and titration, monitoring, adverse effects, and pharmacy/compounding and cost considerations. Taught by a clinician with extensive real-world experience, the presentation highlights where the evidence is strongest and how to implement it. Learners will finish with a concise, evidence-based framework for evaluating and managing CFD in autism within standard practice. |
|
11/12/2025 to 11/30/2027 | $0.00 | $0.00 |
|
Influenza 2025-2026: Is Your Pediatric Practice Ready? 1.0 NAPNAP Contact Hour of which 0.75 contain pharmacology content. This continuing education activity is offered free for NAPNAP Members and non-members. As we enter influenza season, pediatric-focused APRNs can increase their knowledge and prepare to counsel families and restore confidence in influenza vaccines. This continuing education presentation will teach providers to balance communication of scientific data and vaccine efficacy with acknowledgment of parental concerns and fears, and help families feel empowered to make the best decisions when it comes to flu prevention. |
|
11/14/2025 to 11/30/2026 | $0.00 | $0.00 |
|
JPHC CE: Trauma Exposure in Migrant Children: Implications for Mental and Physical Health 1.5 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Global migration is a public health crisis of epidemic proportions. Migrants are at risk for a variety of physical and mental health concerns, while having limited access to healthcare. Migrant children are especially vulnerable to experiencing significant trauma, both physical and emotional. Children comprise less than one third of the global population, yet nearly half of migrants are children less than 18 years of age. The United States is home to a significant number of migrant children. Migrant children have a unique set of educational, health, and emotional needs. Given the sheer number of migrant children living in the U.S., pediatric nurse practitioners (PNP) must understand their unique needs and provide evidence-based interventions to help meet these needs. This continuing education article will discuss migrant children in terms of understanding migration, trauma exposure and resultant impact on psychological and physical health, and implications for practice. J Pediatr Health Care (2025) 40, 1-12. |
|
09/01/2025 to 10/31/2026 | $0.00 | $10.00 |
|
JPHC CE: Patellofemoral Pain Syndrome in Adolescents: Continuing Education for the Primary Care Provider 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Patellofemoral Pain Syndrome (PFPS) is a multifactorial complaint of anterior knee pain. Patellofemoral pain typically spreads diffusely across the knee, is notable during weight bearing, and is exacerbated by knee flexion. Patellofemoral pain is often insidious in onset, typically with no identifiable mechanism of injury. Factors believed to contribute to PFPS include overuse, muscular imbalance, joint malalignment, and, rarely, trauma to the joint (Bump & Lewis, 2023). J Pediatr Health Care (2025) 39, 686-694. |
|
07/01/2025 to 08/31/2026 | $0.00 | $10.00 |